BFRI
Price
$1.01
Change
-$0.03 (-2.88%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
16.78M
47 days until earnings call
Intraday BUY SELL Signals
CABR
Price
$1.15
Change
-$0.04 (-3.36%)
Updated
Oct 2, 04:48 PM (EDT)
Capitalization
12.86M
Intraday BUY SELL Signals
Interact to see
Advertisement

BFRI vs CABR

BFRI vs CABR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BFRI vs. CABR commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and CABR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
BFRICABR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (BFRI: $1.04 vs. CABR: $1.19)
Brand notoriety: BFRI and CABR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 61% vs. CABR: 6%
Market capitalization -- BFRI: $16.78M vs. CABR: $12.86M
BFRI [@Pharmaceuticals: Generic] is valued at $16.78M. CABR’s [@Pharmaceuticals: Generic] market capitalization is $12.86M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 1 FA rating(s) are green while CABR’s FA Score has 0 green FA rating(s).

  • BFRI’s FA Score: 1 green, 4 red.
  • CABR’s FA Score: 0 green, 5 red.
According to our system of comparison, BFRI is a better buy in the long-term than CABR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 5 TA indicator(s) are bullish while CABR’s TA Score has 3 bullish TA indicator(s).

  • BFRI’s TA Score: 5 bullish, 5 bearish.
  • CABR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BFRI is a better buy in the short-term than CABR.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а -13.33% price change this week, while CABR (@Pharmaceuticals: Generic) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

BFRI is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
BFRI
Daily Signal:
Gain/Loss:
CABR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTSO4.050.15
+3.85%
Cytosorbents Corp
PSN41.010.04
+0.10%
Parsons Corp
VMRK60.17-0.59
-0.97%
Vivmark Residential
JBIO13.77-0.28
-1.99%
Jade Biosciences Inc
NKTX2.56-0.06
-2.29%
Nkarta

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and CTOR have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and CTOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-3.70%
CTOR - BFRI
26%
Poorly correlated
-2.97%
ACET - BFRI
25%
Poorly correlated
-7.00%
SBFM - BFRI
23%
Poorly correlated
-11.07%
LNTH - BFRI
23%
Poorly correlated
+0.12%
CABR - BFRI
23%
Poorly correlated
N/A
More

CABR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABR has been loosely correlated with TLRY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CABR jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABR
1D Price
Change %
CABR100%
N/A
TLRY - CABR
38%
Loosely correlated
-4.80%
BFRI - CABR
23%
Poorly correlated
-3.70%
AKAN - CABR
7%
Poorly correlated
-14.01%
IXHL - CABR
7%
Poorly correlated
+0.31%
SHPH - CABR
6%
Poorly correlated
-0.74%
More